Regulatory modernization to support innovation and growth
Innovation in the pharmaceutical industry requires the right incentives, and such incentives can be diverse. Sufficient regulatory protection and adequate
Read moreInnovation in the pharmaceutical industry requires the right incentives, and such incentives can be diverse. Sufficient regulatory protection and adequate
Read moreThe European Health Data Space (EHDS) represents one of the central building blocks of the European Health Union and a
Read moreHow the EU Pharmaceutical Package impacts smaller companies and orphan developers The EU Pharmaceutical Package represents a unique opportunity to
Read moreAccess to affordable medicines represents a universal human right and a significant target included in the Sustainable Development Goals of
Read moreEuropean healthcare stands at a pivotal moment. The pandemic may feel a lifetime ago, but we are yet to fully
Read moreThe COVID-19 crisis exposed the vulnerabilities of national healthcare systems and highlighted the importance of health policies that truly address
Read moreWhile Europe wrestles with pressing questions over its health strategy following the end of the COVID-19 public health emergency, practical
Read moreWith 7million reported COVID-19 deaths and over 19 million excess deaths estimated worldwide by January 2023, COVID-19 brought to the
Read more